This form of altered hemoglobin may contribute to the progression of NAFLD either directly, by stimulating RAGE or indirectly, through the promotion of hypoxia and suppression of the release of NO. This evidence concerns the gene AGER and metabolic dysfunction-associated steatotic liver disease.